Results 71 to 80 of about 6,795,417 (124)

Gender disparities in heart failure with mid-range and preserved ejection fraction: Results from APOLLON study

, 2019
Mert, Kadir Ugur/0000-0002-1331-5365; Agus, Hicaz Zencirkiran/0000-0002-5882-0525;WOS: 000468584800003PubMed ID: 31062760Objective: This study aimed to examine gender-based differences in epidemiology, clinical characteristics, and management of ...
Çelik, Oğuzhan, Cil, Cem, Özlek, Bülent, Biteker, Murat, Agus, Hicaz Zencirkiran, Ozlek, Eda, Kahraman, Serkan, Tekinalp, Mehmet   +7 more
core   +2 more sources

Atrial fibrillation ablation in heart failure with mid-range ejection fraction: Is it time to open the champagne? [PDF]

Indian Pacing Electrophysiol J, 2023
Nagarakanti R, Gopinathannair R.
europepmc   +1 more source

Myocardial strain may predict exercise tolerance in patients with reduced and mid-range ejection fraction

Hellenic Journal of Cardiology, 2018
Background: Conventional echocardiographic parameters, such as rest ejection fraction, perform poorly in the prediction of exercise tolerance in heart failure.
Elias Tsougos, George Angelidis, Elias Gialafos, Chara Tzavara, Vaios Tzifos, Ioannis Tsougos, Panagiotis Georgoulias   +6 more
doaj   +1 more source

Central and Obstructive Apneas in Heart Failure With Reduced, Mid-Range and Preserved Ejection Fraction

Frontiers in Cardiovascular Medicine, 2019
Background: Although central apneas (CA) and obstructive apneas (OA) are highly prevalent in heart failure (HF), a comparison of apnea prevalence, predictors and clinical correlates in the whole HF spectrum, including HF with reduced ejection fraction ...
Chiara Borrelli, Chiara Borrelli, Chiara Borrelli, Francesco Gentile, Paolo Sciarrone, Gianluca Mirizzi, Gianluca Mirizzi, Giuseppe Vergaro, Giuseppe Vergaro, Nicolò Ghionzoli, Francesca Bramanti, Giovanni Iudice, Claudio Passino, Claudio Passino, Michele Emdin, Michele Emdin, Alberto Giannoni, Alberto Giannoni   +17 more
doaj   +1 more source

The correlation of left atrial diameter with preserved ejection fraction, reduced ejection fraction, and mid-range ejection fraction. [PDF]

Clin Cardiol, 2023
Lin J, Wu H, Zhang T.
europepmc   +1 more source

Sex differences in mortality and hospitalization in heart failure with preserved and mid-range ejection fraction: a systematic review and meta-analysis of cohort studies. [PDF]

Front Cardiovasc Med, 2023
Deng Y, Zhang J, Ling J, Hu Q, Song T, Xu Y, Liu M, Wu Y, Mei K, Chen J, Zhao H, Liu X.   +11 more
europepmc   +1 more source

Similar predictive value of six-minute walking distance and B-type natriuretic peptide in heart failure with reduced to mid-range ejection fraction

Monaldi Archives for Chest Disease, 2019
The prognostic insights of heart failure (HF) with mid-range (40-49%) ejection fraction (HFmrEF) are not fully elucidated. We investigated whether the six-minutes walking test (6MWT) and brain natriuretic peptide (BNP) are predictive of outcome across ...
Angela Beatrice Scardovi, Renata De Maria, Gian Giacomo Galeotti, Pompilio Faggiano, Luca Arcari, Stefano Ghio, Pier Luigi Temporelli, Andrea Rossi, Giovanna Magni, Anca Simioniuc, Roberto Ricci, Frank Lloyd Dini   +11 more
doaj   +1 more source

Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction

, 2017
OBJECTIVES The study sought to assess the independent risk factors for, consequences of, and outcomes with atrial fibrillation (AF) compared with sinus rhythm (SR) in heart failure (HF) with preserved ejection fraction (HFpEF) versus HF with mid-range ...
Michael Fu, Ulf Dahlström, Dahlström, Ulf,, Lund, Lars H.,, Lars H. Lund, Ulrik Sartipy, Fu, Michael,, Sartipy, Ulrik,   +7 more
core   +1 more source

Outcomes in Patients With Atrial Fibrillation Stratified by Body Mass Index and Heart Failure Status

JACC: Advances
Background: An obesity-survival benefit, called the “obesity paradox,” has been variably reported in patients with heart failure (HF) and those with atrial fibrillation (AF), but inconsistencies have been observed.
Jean Jacques Noubiap, MD, PhD, Lisa A. Kaltenbach, MS, Karen Chiswell, PhD, Ulrich Flore Nyaga, MD, MPH, Mina K. Chung, MD, Jeroen M. Hendriks, RN, PhD, Larry R. Jackson, II, MD, MHSc, Andrea M. Russo, MD, Annabelle Santos Volgman, MD, Meghan Reading Turchioe, PhD, RN, Ohad Ziv, MD, Jonathan P. Piccini, MD, MHS, Prashanthan Sanders, MBBS, PhD   +12 more
doaj   +1 more source

Potention of L-carnitine supplementation on changes in ejection fraction and left ventricular dimension in case of dilatative cardiomyopathy in children [PDF]

, 2020
Background: Cardiomyopathy is a rare cardiac muscle disease with poor prognosis and high mortality. The main goal of dilated cardiomyopathy therapy is to restore and maximize cardiac function, but to date no medication has met these criteria.
Wahyu Wibowo, -, I Ketut Alit Utamayasa, -, Mahrus A. Rahman, -   +2 more
core   +1 more source